Susquehanna International Group
FLNA

Susquehanna International Group’s Filana Therapeutics FLNA Stock Holding History

Susquehanna International Group’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$210K Buy
124,400
+34,400
+38% +$70.8K ﹤0.01% 11599
2025
Q4 		$178K Sell
90,000
-178,200
-66% -$571K ﹤0.01% 11008
2025
Q3 		$780K Buy
268,200
+109,100
+69% +$251K ﹤0.01% 7925
2025
Q2 		$288K Sell
159,100
-113,300
-42% -$202K ﹤0.01% 10432
2025
Q1 		$409K Sell
272,400
-866,400
-76% -$2.19M ﹤0.01% 9350
2024
Q4 		$2.69M Buy
1,138,800
+388,800
+52% +$6.83M ﹤0.01% 4680
2024
Q3 		$22.1M Buy
750,000
+472,700
+170% +$10.9M ﹤0.01% 1737
2024
Q2 		$3.42M Sell
277,300
-237,100
-46% -$5M ﹤0.01% 4080
2024
Q1 		$10.4M Sell
514,400
-260,000
-34% -$5.99M ﹤0.01% 2541
2023
Q4 		$17.4M Sell
774,400
-88,800
-10% -$1.88M ﹤0.01% 1959
2023
Q3 		$14.4M Buy
863,200
+413,300
+92% +$8.19M ﹤0.01% 2115
2023
Q2 		$11M Sell
449,900
-193,900
-30% -$4.67M ﹤0.01% 2384
2023
Q1 		$15.5M Sell
643,800
-280,500
-30% -$7.77M ﹤0.01% 1951
2022
Q4 		$27.3M Sell
924,300
-398,200
-30% -$14.3M 0.01% 1261
2022
Q3 		$55.3M Buy
1,322,500
+434,000
+49% +$11.7M 0.01% 753
2022
Q2 		$25M Buy
888,500
+59,300
+7% +$1.5M 0.01% 1278
2022
Q1 		$30.8M Sell
829,200
-207,100
-20% -$8.77M 0.01% 1327
2021
Q4 		$45.3M Sell
1,036,300
-264,000
-20% -$13.8M 0.01% 1168
2021
Q3 		$80.7M Buy
1,300,300
+846,900
+187% +$70.7M 0.01% 889
2021
Q2 		$38.7M Buy
453,400
+80,500
+22% +$4.31M 0.01% 1392
2021
Q1 		$16.8M Buy
372,900
+329,200
+753% +$12.9M ﹤0.01% 2103
2020
Q4 		$298K Sell
43,700
-31,900
-42% -$285K ﹤0.01% 9270
2020
Q3 		$870K Sell
75,600
-55,200
-42% -$249K ﹤0.01% 6463
2020
Q2 		$403K Buy
130,800
+42,500
+48% +$193K ﹤0.01% 7810
2020
Q1 		$363K Buy
+88,300
New +$585K ﹤0.01% 7611
2016
Q4 		– Sell
-42,886
Closed -$300K – 10072
2016
Q3 		$300K Buy
+42,886
New +$711K ﹤0.01% 6935
2015
Q1 		– Sell
-2,543
Closed -$36K – 9865
2014
Q4 		$36K Sell
2,543
-3,028
-54% -$52.4K ﹤0.01% 9425
2014
Q3 		$152K Sell
5,571
-4,272
-43% -$130K ﹤0.01% 8875
2014
Q2 		$396K Sell
9,843
-7,914
-45% -$293K ﹤0.01% 7902
2014
Q1 		$684K Buy
17,757
+8,028
+83% +$283K ﹤0.01% 6195
2013
Q4 		$331K Buy
9,729
+5,258
+118% +$140K ﹤0.01% 7430
2013
Q3 		$85K Sell
4,471
-1,015
-19% -$17.7K ﹤0.01% 8128
2013
Q2 		$85K Buy
+5,486
New +$116K ﹤0.01% 7847

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Susquehanna International Group's FLNA Position: Q1 2026 in Review

Susquehanna International Group reduced its Filana Therapeutics (FLNA) stake by 15% in Q1 2026, selling an estimated $166K and leaving 447,278 shares worth $756K. The position accounts for ﹤0.01% of the portfolio, ranked #8619.

Susquehanna International Group first reported a position in FLNA in Q2 2013 and has held it in 49 quarters since. The position peaked at $30M in Q2 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Susquehanna International Group held 447,278 shares of Filana Therapeutics worth $756K as of Q1 2026.
  • Susquehanna International Group sold 80,740 Filana Therapeutics shares in Q1 2026, an estimated $166K.
  • Filana Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8619 holding.
  • Susquehanna International Group first reported a position in Filana Therapeutics in Q2 2013 and has held it in 49 quarters since.
  • Susquehanna International Group's Filana Therapeutics position peaked at $30M in Q2 2021.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.